Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital

Dal - Gene

Projekt: Typer af projekter

Vis graf over relationer
A Phase III, Double-blind, Randomized Placebo-controlled Study to Evaluate the Effects of Dalcetrapib on Cardiovascular (CV) Risk in a Genetically Defined Population With a Recent Acute Coronary Syndrome (ACS): The Dal-GenE Trial

www.clinicaltrials.gov : NCT02525939
StatusIgangværende
Periode01/04/201601/08/2020

ID: 58247364